Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 66
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Genes (Basel) ; 10(7)2019 07 12.
Artículo en Inglés | MEDLINE | ID: mdl-31336972

RESUMEN

Occipital horn syndrome (OHS) is a rare connective tissue disorder caused by pathogenic variants in ATP7A, encoding a copper transporter. The main clinical features, including cutis laxa, bony exostoses, and bladder diverticula are attributed to a decreased activity of lysyl oxidase (LOX), a cupro-enzyme involved in collagen crosslinking. The absence of large case series and natural history studies precludes efficient diagnosis and management of OHS patients. This study describes the clinical and molecular characteristics of two new patients and 32 patients previously reported in the literature. We report on the need for long-term specialized care and follow-up, in which MR angiography, echocardiography and spirometry should be incorporated into standard follow-up guidelines for OHS patients, next to neurodevelopmental, orthopedic and urological follow-up. Furthermore, we report on ultrastructural abnormalities including increased collagen diameter, mild elastic fiber abnormalities and multiple autophagolysosomes reflecting the role of lysyl oxidase and defective ATP7A trafficking as pathomechanisms of OHS.


Asunto(s)
Cutis Laxo/patología , Síndrome de Ehlers-Danlos/patología , Adolescente , Adulto , Niño , Preescolar , Colágeno/metabolismo , ATPasas Transportadoras de Cobre/genética , Cutis Laxo/enzimología , Cutis Laxo/genética , Divertículo/patología , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/genética , Humanos , Lactante , Masculino , Persona de Mediana Edad , Proteína-Lisina 6-Oxidasa/metabolismo , Vejiga Urinaria/anomalías , Vejiga Urinaria/patología , Adulto Joven
2.
Am J Med Genet A ; 176(11): 2331-2341, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30195269

RESUMEN

Musculocontractural Ehlers-Danlos syndrome caused by mutations in CHST14 (mcEDS-CHST14) is a recently delineated disorder, characterized by craniofacial, skeletal, visceral, and ocular malformations; and progressive cutaneous, skeletal, vascular, and visceral fragility-related manifestations. Spinal lesions, though one of the most serious complications, have not been investigated systematically. In this study, we report detailed and comprehensive information about spinal lesions of 12 patients with a mean age at the first visit of 13.4 years. Eight patients (66.7%) had scoliosis with a Cobb angle ≥10°, including one with severe scoliosis with a Cobb angle ≥45°. Five patients (41.7%) had kyphosis at the thoracolumbar junction with a kyphotic angle ≥20°. Three patients (25%) developed severe thoracolumbar kyphosis with a kyphotic angle ≥50° accompanied by thoracic lordosis with a wedge-like vertebral deformity and anterior vertebral osteophyte at the thoracolumbar junction, and two of them underwent surgical correction: complicated by fistula formation in one and performed safely and effectively through two-staged operation in the other. Six patients (50.0%) had cervical kyphosis, all of whom except one had kyphosis ≥20° at the thoracolumbar level. Two patients (16.7%) had atlantoaxial subluxation, and 10 patients (83.3%) had cervical vertebral malformations. Patients with mcEDS-CHST14 are susceptible to develop scoliosis, thoracolumbar kyphosis, and cervical kyphosis; and are recommended to have regular surveillance including total spine radiology. The present findings also suggest the critical role of dermatan sulfate in the development and maintenance of the spine.


Asunto(s)
Síndrome de Ehlers-Danlos/enzimología , Médula Espinal/patología , Sulfotransferasas/deficiencia , Adolescente , Adulto , Vértebras Cervicales/diagnóstico por imagen , Vértebras Cervicales/patología , Niño , Preescolar , Síndrome de Ehlers-Danlos/diagnóstico por imagen , Femenino , Humanos , Masculino , Médula Espinal/diagnóstico por imagen , Médula Espinal/cirugía , Sulfotransferasas/metabolismo , Tomografía Computarizada por Rayos X , Adulto Joven
3.
Hum Mol Genet ; 27(20): 3475-3487, 2018 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-29931299

RESUMEN

Proteoglycans are among the most abundant and structurally complex biomacromolecules and play critical roles in connective tissues. They are composed of a core protein onto which glycosaminoglycan (GAG) side chains are attached via a linker region. Biallelic mutations in B3GALT6, encoding one of the linker region glycosyltransferases, are known to cause either spondyloepimetaphyseal dysplasia (SEMD) or a severe pleiotropic form of Ehlers-Danlos syndromes (EDS). This study provides clinical, molecular and biochemical data on 12 patients with biallelic B3GALT6 mutations. Notably, all patients have features of both EDS and SEMD. In addition, some patients have severe and potential life-threatening complications such as aortic dilatation and aneurysm, cervical spine instability and respiratory insufficiency. Whole-exome sequencing, next generation panel sequencing and direct sequencing identified biallelic B3GALT6 mutations in all patients. We show that these mutations reduce the amount of ß3GalT6 protein and lead to a complete loss of galactosyltransferase activity. In turn, this leads to deficient GAG synthesis, and ultrastructural abnormalities in collagen fibril organization. In conclusion, this study redefines the phenotype associated with B3GALT6 mutations on the basis of clinical, molecular and biochemical data in 12 patients, and provides an in-depth assessment of ß3GalT6 activity and GAG synthesis to better understand this rare condition.


Asunto(s)
Síndrome de Ehlers-Danlos/genética , Secuenciación del Exoma , Galactosiltransferasas/genética , Mutación , Fenotipo , Adulto , Niño , Preescolar , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/patología , Pruebas de Enzimas , Femenino , Galactosiltransferasas/metabolismo , Expresión Génica , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Lactante , Masculino
5.
Pediatr Int ; 58(2): 88-99, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26646600

RESUMEN

Carbohydrate sulfotransferase 14/dermatan 4-O-sulfotransferase-1 (CHST14/D4ST1) deficiency represents a specific form of Ehlers-Danlos syndrome (EDS) caused by recessive loss-of-function mutations in CHST14. The disorder has been independently termed "adducted thumb-clubfoot syndrome", "EDS, Kosho type", and "EDS, musculocontractural type". To date, 31 affected patients from 21 families have been described. Clinically, CHST14/D4ST1 deficiency is characterized by multiple congenital malformations (craniofacial features including large fontanelle, hypertelorism, short and downslanting palpebral fissures, blue sclerae, short nose with hypoplastic columella, low-set and rotated ears, high palate, long philtrum, thin upper lip vermilion, small mouth, and micro-retrognathia; multiple congenital contractures including adduction-flexion contractures and talipes equinovarus as well as other visceral or ophthalmological malformations) and progressive multisystem fragility-related complications (skin hyperextensibility, bruisability, and fragility with atrophic scars; recurrent dislocations; progressive talipes or spinal deformities; pneumothorax or pneumohemothorax; large subcutaneous hematomas; and diverticular perforation). Etiologically, multisystem fragility is presumably caused by impaired assembly of collagen fibrils resulting from loss of dermatan sulfate (DS) in the decorin glycosaminoglycan side chain that promotes electrostatic binding between collagen fibrils. This is the first reported human disorder that specifically affects biosynthesis of DS. Its clinical characteristics indicate that CHST14/D4ST1 and, more fundamentally, DS, play a critical role in fetal development and maintenance of connective tissues in multiple organs. Considering that patients with CHST14/D4ST1 deficiency develop progressive multisystem fragility-related manifestations, establishment of a comprehensive and detailed natural history and health-care guidelines as well as further elucidation of the pathophysiology in view of future etiology-based therapy are crucial.


Asunto(s)
Dermatán Sulfato/biosíntesis , Síndrome de Ehlers-Danlos/enzimología , Sulfotransferasas/deficiencia , Adolescente , Animales , Niño , Preescolar , Síndrome de Ehlers-Danlos/diagnóstico , Síndrome de Ehlers-Danlos/genética , Femenino , Humanos , Lactante , Masculino , Mutación , Sulfotransferasas/genética , Adulto Joven
6.
Biomed Res Int ; 2015: 861752, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26582078

RESUMEN

Glycosaminoglycans, including chondroitin, dermatan, and heparan sulfate, have various roles in a wide range of biological events such as cell signaling, cell proliferation, tissue morphogenesis, and interactions with various growth factors. Their polysaccharides covalently attach to the serine residues on specific core proteins through the common linker region tetrasaccharide, -xylose-galactose-galactose-glucuronic acid, which is produced through the stepwise addition of respective monosaccharides by four distinct glycosyltransferases. Mutations in the human genes encoding the glycosyltransferases responsible for the biosynthesis of the linker region tetrasaccharide cause a number of genetic disorders, called glycosaminoglycan linkeropathies, including Desbuquois dysplasia type 2, spondyloepimetaphyseal dysplasia, Ehlers-Danlos syndrome, and Larsen syndrome. This review focused on recent studies on genetic diseases caused by defects in the biosynthesis of the common linker region tetrasaccharide.


Asunto(s)
Anomalías Craneofaciales/genética , Enanismo/genética , Síndrome de Ehlers-Danlos/genética , Glicosiltransferasas/genética , Inestabilidad de la Articulación/genética , Osificación Heterotópica/genética , Osteocondrodisplasias/genética , Polidactilia/genética , Proliferación Celular/genética , Condroitín/metabolismo , Anomalías Craneofaciales/enzimología , Anomalías Craneofaciales/metabolismo , Dermatán Sulfato/metabolismo , Enanismo/enzimología , Enanismo/metabolismo , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/metabolismo , Heparitina Sulfato/metabolismo , Humanos , Inestabilidad de la Articulación/enzimología , Inestabilidad de la Articulación/metabolismo , Morfogénesis/genética , Mutación , Osificación Heterotópica/enzimología , Osificación Heterotópica/metabolismo , Osteocondrodisplasias/enzimología , Osteocondrodisplasias/metabolismo , Polidactilia/enzimología , Polidactilia/metabolismo
7.
J Biol Chem ; 290(26): 16440-50, 2015 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-25979340

RESUMEN

Lysyl oxidases (LOXs) are a family of copper-dependent oxido-deaminases that can modify the side chain of lysyl residues in collagen and elastin, thereby leading to the spontaneous formation of non-reducible aldehyde-derived interpolypeptide chain cross-links. The consequences of LOX inhibition in producing lathyrism are well documented, but the consequences on collagen fibril formation are less clear. Here we used ß-aminoproprionitrile (BAPN) to inhibit LOX in tendon-like constructs (prepared from human tenocytes), which are an experimental model of cell-mediated collagen fibril formation. The improvement in structure and strength seen with time in control constructs was absent in constructs treated with BAPN. As expected, BAPN inhibited the formation of aldimine-derived cross-links in collagen, and the constructs were mechanically weak. However, an unexpected finding was that BAPN treatment led to structurally abnormal collagen fibrils with irregular profiles and widely dispersed diameters. Of special interest, the abnormal fibril profiles resembled those seen in some Ehlers-Danlos Syndrome phenotypes. Importantly, the total collagen content developed normally, and there was no difference in COL1A1 gene expression. Collagen type V, decorin, fibromodulin, and tenascin-X proteins were unaffected by the cross-link inhibition, suggesting that LOX regulates fibrillogenesis independently of these molecules. Collectively, the data show the importance of LOX for the mechanical development of early collagenous tissues and that LOX is essential for correct collagen fibril shape formation.


Asunto(s)
Síndrome de Ehlers-Danlos/enzimología , Colágenos Fibrilares/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Tendones/enzimología , Adolescente , Adulto , Síndrome de Ehlers-Danlos/genética , Síndrome de Ehlers-Danlos/metabolismo , Femenino , Colágenos Fibrilares/genética , Humanos , Masculino , Proteína-Lisina 6-Oxidasa/genética , Tendones/metabolismo , Adulto Joven
8.
Eur J Pediatr ; 174(1): 105-12, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25277362

RESUMEN

UNLABELLED: The kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA) is a rare recessively inherited connective tissue disorder characterized by bruisable, hyperextensible skin, generalized joint laxity, severe muscular hypotonia at birth and progressive congenital scoliosis or kyphosis. Deficiency of the enzyme lysyl hydroxylase 1 (LH1) due to mutations in PLOD1 results in underhydroxylation of collagen lysyl residues and, hence, in the abnormal formation of collagen cross-links. Here, we report on the clinical, biochemical, and molecular findings in six Egyptian patients from four unrelated families severely affected with EDS VIA. In addition to the frequently reported p.Glu326_Lys585dup, we identified two novel sequence variants p.Gln208* and p.Tyr675*, which lead either to loss of function of LH1 or to its deficiency. All affected children presented with similar clinical features of the disorder, and in addition, several dysmorphic craniofacial features, not yet described in EDS VIA. These were specific for the affected individuals of each family, but absent in their parents and their unaffected siblings. CONCLUSION: Our description of six patients presenting with a homogeneous clinical phenotype and dysmorphic craniofacial features will help pediatricians in the diagnosis of this rare disorder.


Asunto(s)
Síndrome de Ehlers-Danlos/diagnóstico , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/deficiencia , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/genética , Niño , Preescolar , Anomalías Craneofaciales/etiología , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/genética , Femenino , Humanos , Lactante , Masculino , Fenotipo
9.
J Histochem Cytochem ; 60(12): 916-25, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22899863

RESUMEN

The ability of chondroitin/dermatan sulfate (CS/DS) to convey biological information is enriched by the presence of iduronic acid. DS-epimerases 1 and 2 (DS-epi1 and 2), in conjunction with DS-4-O-sulfotransferase 1, are the enzymes responsible for iduronic acid biosynthesis and will be the major focus of this review. CS/DS proteoglycans (CS/DS-PGs) are ubiquitously found in connective tissues, basement membranes, and cell surfaces or are stored intracellularly. Such wide distribution reflects the variety of biological roles in which they are involved, from extracellular matrix organization to regulation of processes such as proliferation, migration, adhesion, and differentiation. They play roles in inflammation, angiogenesis, coagulation, immunity, and wound healing. Such versatility is achieved thanks to their variable composition, both in terms of protein core and the fine structure of the CS/DS chains. Excellent reviews have been published on the collective and individual functions of each CS/DS-PG. This short review presents the biosynthesis and functions of iduronic acid-containing structures, also as revealed by the analysis of the DS-epi1- and 2-deficient mouse models.


Asunto(s)
Dermatán Sulfato/fisiología , Ácido Idurónico/metabolismo , Animales , Biocatálisis , Trastorno Bipolar/enzimología , Trastorno Bipolar/genética , Carbohidrato Epimerasas/química , Carbohidrato Epimerasas/genética , Carbohidrato Epimerasas/metabolismo , Dermatán Sulfato/biosíntesis , Dermatán Sulfato/química , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/genética , Humanos , Ratones , Ratones Noqueados , Estructura Molecular , Neoplasias/metabolismo , Sulfotransferasas/metabolismo
10.
J Pharmacol Exp Ther ; 343(1): 246-51, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22815532

RESUMEN

There is no proven therapy or prevention for vascular Ehlers-Danlos syndrome (vEDS), a genetic disorder associated with the mutation of procollagen type III and characterized by increased fragility of vascular and hollow organ walls. Heterozygous COL3A1-deficient (HT) mice recapitulate a mild presentation of one of the variants of vEDS: haploinsufficiency for collagen III. Adult HT mice are characterized by increased metalloproteinase (MMP) activity, reduced collagen content in the arterial walls, and spontaneous development of various severity lesions in aorta. We hypothesized that chronic treatment with a MMP inhibitor would increase collagen content and prevent the development of spontaneous aortic lesions. HT mice were treated since weaning with the broad-spectrum MMP inhibitor doxycycline added to food. At the age of 9 months MMP-9 expression was twice as high in the tunica media of aorta in untreated HT mice, whereas total collagen content was 30% lower (p < 0.01) and the cumulative score of aortic lesions was eight times higher than in wild-type (WT) mice (p < 0.01). After 9 months of doxycycline treatment, MMP-9 activity, collagen content, and lesions in the aortas of HT mice were at the level of those of WT mice (p > 0.05). In the mouse model of collagen III haploinsufficiency treatment with broad-spectrum MMP inhibitor that was started early in life normalized increased MMP activity, reduced aortic collagen content in adults, and prevented the development of spontaneous aortic lesions. Our findings provide experimental justification for the clinical evaluation of the benefit of doxycycline at least in the haploinsufficient variety of vEDS.


Asunto(s)
Aorta Torácica/efectos de los fármacos , Modelos Animales de Enfermedad , Doxiciclina/administración & dosificación , Síndrome de Ehlers-Danlos/tratamiento farmacológico , Síndrome de Ehlers-Danlos/patología , Inhibidores de la Metaloproteinasa de la Matriz/administración & dosificación , Animales , Aorta Torácica/enzimología , Aorta Torácica/patología , Síndrome de Ehlers-Danlos/enzimología , Ratones , Ratones Noqueados , Resultado del Tratamiento
11.
Am J Med Genet A ; 155A(8): 1949-58, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21744491

RESUMEN

Loss-of-function mutations in CHST14, dermatan 4-O-sulfotransferase 1 (D4ST1) deficiency, have recently been found to cause adducted thumb-clubfoot syndrome (ATCS; OMIM#601776) and a new type of Ehlers-Danlos syndrome (EDS) coined as EDS Kosho Type (EDSKT) [Miyake et al., 2010], as well as a subset of kyphoscoliosis type EDS without lysyl hydroxylase deficiency (EDS VIB) coined as musculocontractural EDS (MCEDS) [Malfait et al., 2010]. Lack of detailed clinical information from later childhood to adulthood in ATCS and lack of detailed clinical information from birth to early childhood in EDSKT and MCEDS have made it difficult to determine whether these disorders would be distinct clinical entities or a single clinical entity with variable expressions and with different presentations depending on the patients' ages at diagnosis. We present detailed clinical findings and courses of two additional unrelated patients, aged 2 years and 6 years, with EDSKT with a comprehensive review of 20 reported patients with D4ST1 deficiency, which supports the notion that these disorders constitute a clinically recognizable form of EDS. The disorder, preferably termed D4ST1-deficient EDS, is characterized by progressive multisystem fragility-related manifestations (joint dislocations and deformities, skin hyperextensibility, bruisability, and fragility; recurrent large subcutaneous hematomas, and other cardiac valvular, respiratory, gastrointestinal, and ophthalmological complications) resulting from impaired assembly of collagen fibrils, as well as various malformations (distinct craniofacial features, multiple congenital contractures, and congenital defects in cardiovascular, gastrointestinal, renal, ocular, and central nervous systems) resulting from inborn errors of development.


Asunto(s)
Anomalías Múltiples/genética , Síndrome de Ehlers-Danlos/enzimología , Sulfotransferasas/deficiencia , Niño , Preescolar , Pie Equinovaro/cirugía , Anomalías Craneofaciales/genética , Criptorquidismo/genética , Análisis Mutacional de ADN , Discapacidades del Desarrollo/genética , Síndrome de Ehlers-Danlos/genética , Estudios de Asociación Genética , Humanos , Masculino , Fenotipo , Sulfotransferasas/genética
12.
Biochem J ; 432(2): 303-11, 2010 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-20809901

RESUMEN

Three mutations of the B4GALT7 gene [encoding ß1,4-GalT7 (ß1,4-galactosyltransferase 7)], corresponding to A186D, L206P and R270C, have been identified in patients with the progeroid form of the Ehlers-Danlos syndrome and are described as being associated with the reduction or loss of ß1,4-GalT7 activity. However, the molecular basis of the reduction or loss of activity remained to be determined. In the present study, wild-type, A186D, L206P and R270C ß1,4-GalT7 were expressed in CHO618 cells as membrane proteins and in Escherichia coli as soluble proteins fused to MBP (maltose-binding protein). The ability of the expressed proteins to transfer galactose from donor to acceptor substrates was systematically characterized by kinetic analysis. The physicochemical properties of soluble proteins were explored by isothermal titration calorimetry, which is a method of choice when determining the thermodynamic parameters of the binding of substrates. Together, the results showed that: (i) the L206P mutation abolished the activity when L206P ß1,4GalT7 was either inserted in the membrane or expressed as a soluble MBP-full-length fusion protein; (ii) the A186D mutation weakly impaired the binding of the donor substrate; and (iii) the R270C mutation strongly impaired the binding of the acceptor substrate. Moreover, the ex vivo consequences of the mutations were investigated by evaluating the priming efficiency of xylosides on GAG (glycosaminoglycan) chain initiation. The results demonstrate a quantitative effect on GAG biosynthesis, depending on the mutation; GAG biosynthesis was fully inhibited by the L206P mutation and decreased by the R270C mutation, whereas the A186D mutation did not affect GAG biosynthesis severely.


Asunto(s)
Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/genética , Galactosiltransferasas/genética , Animales , Células CHO , Clonación Molecular , Cricetinae , Cricetulus , Galactosiltransferasas/química , Galactosiltransferasas/metabolismo , Humanos , Cinética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , Termodinámica
13.
FEBS Lett ; 584(18): 3962-8, 2010 Sep 24.
Artículo en Inglés | MEDLINE | ID: mdl-20691685

RESUMEN

ß1,4-Galactosyltransferase 7 (ß4GalT7) is a key enzyme initiating glycosaminoglycan (GAG) synthesis. Based on in vitro and ex vivo kinetics studies and structure-based modelling, we molecularly characterized ß4GalT7 mutants linked to the progeroid form of Ehlers-Danlos syndrome (EDS), a severe connective tissue disorder. Our results revealed that loss of activity upon L206P substitution due to altered protein folding is the primary cause for the GAG synthesis defect in patients carrying the compound A186D and L206P mutations. We showed that R270C substitution strongly reduced ß4GalT7 affinity towards xyloside acceptor, thus affecting GAG chains formation. This study establishes the molecular basis for ß4GalT7 defects associated with altered GAG synthesis in EDS.


Asunto(s)
Síndrome de Ehlers-Danlos/enzimología , Galactosiltransferasas/metabolismo , Glicosaminoglicanos/biosíntesis , Animales , Células CHO , Cricetinae , Cricetulus , Síndrome de Ehlers-Danlos/genética , Galactosiltransferasas/química , Galactosiltransferasas/genética , Humanos , Modelos Moleculares , Mutación
14.
Hum Mutat ; 31(8): 966-74, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20533528

RESUMEN

Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of the N-acetyl-D-galactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.


Asunto(s)
Síndrome de Ehlers-Danlos/clasificación , Síndrome de Ehlers-Danlos/genética , Mutación/genética , Sulfotransferasas/genética , Adulto , Secuencia de Aminoácidos , Niño , Colágeno/metabolismo , Decorina , Dermis/patología , Síndrome de Ehlers-Danlos/enzimología , Proteínas de la Matriz Extracelular/metabolismo , Femenino , Fibroblastos/metabolismo , Fibroblastos/patología , Glicosaminoglicanos/metabolismo , Humanos , Masculino , Modelos Biológicos , Datos de Secuencia Molecular , Linaje , Proteoglicanos/metabolismo , Transducción de Señal , Sulfotransferasas/química , Factor de Crecimiento Transformador beta , Carbohidrato Sulfotransferasas
16.
Clin Biochem ; 42(6): 521-7, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19133250

RESUMEN

OBJECTIVES: Patients with Ehlers-Danlos syndrome were described to contain reduced activities of beta4-galactosyltransferase-7 (beta4Gal-T7). Therefore, measurement of beta4Gal-T7 activity can help to characterize defects in proteoglycan biosynthesis in patients with connective tissue diseases. DESIGN AND METHODS: We developed a sensitive and specific method to assay beta4Gal-T7 which is based on the transfer of galactose from UDP-galactose to the synthetic peptide Bio-BIK-F-Xyl. RESULTS: Calibration curves exhibited consistent linearity in the range of 10-2000 microg/L Bio-BIK-F-Xyl-Gal, corresponding to a beta4Gal-T7 activity of 3.5-659 microU/L. The limit of detection and the lower limit of quantification were 3.70 microg/L (1.22 microU/L) and 4.50 microg/L Bio-BIK-F-Xyl-Gal (1.48 microU/L beta4Gal-T7 activity), respectively. Interassay imprecision (CV) was 8.1-13.1% in the range from 15.9 to 659 microU/L, and mean recovery was 85.3% (range 61.7-106.3%). CONCLUSIONS: This sensitive, robust and interference-free LC-MS/MS assay allows an accurate determination of beta4Gal-T7 activity in human body fluids.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Galactosiltransferasas/metabolismo , Espectrometría de Masa por Ionización de Electrospray/métodos , Animales , Calibración , Técnicas de Cultivo de Célula , Síndrome de Ehlers-Danlos/sangre , Síndrome de Ehlers-Danlos/enzimología , Femenino , Galactosa/metabolismo , Humanos , Masculino , Sensibilidad y Especificidad , Uridina Difosfato Galactosa/metabolismo
17.
Hum Mol Genet ; 17(7): 996-1009, 2008 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-18158310

RESUMEN

Reduced activity of beta4-galactosyltransferase 7 (beta4GalT-7), an enzyme involved in synthesizing the glycosaminoglycan linkage region of proteoglycans, is associated with the progeroid form of Ehlers-Danlos syndrome (EDS). In the invertebrates Drosophila melanogaster and Caenorhabditis elegans, mutations in beta4GalT-7 affect biosynthesis of heparan sulfate (HS), a modulator of several biological processes relevant to wound repair. We have analyzed structural alterations of HS and their functional consequences in human beta4GalT-7 Arg270Cys mutant EDS and control fibroblasts. HS disaccharide analysis by reversed phase ion-pairing chromatography revealed a reduced sulfation degree of HS paralleled by altered immunostaining patterns for the phage-display anti-HS antibodies HS4E4 and RB4EA12 in beta4GalT-7 mutant fibroblasts. Real-time PCR-analysis of 44 genes involved in glycosaminoglycan biosynthesis indicated that the structural alterations in HS were not caused by differential regulation at the transcriptional level. Scratch wound closure was delayed in beta4GalT-7-deficient cells, which could be mimicked by enzymatic removal of HS in control cells. siRNA-mediated knockdown of beta4GalT-7 expression induced morphological changes in control fibroblasts which suggested altered cell-matrix interactions. Adhesion of beta4GalT-7 deficient cells to fibronectin was increased while actin stress fiber formation was impaired relative to control cells. Also collagen gel contraction was delayed in the beta4GalT-7 mutants which showed a reduced formation of pseudopodia and filopodia, less efficient penetration of the collagen gels and a diminished formation of collagen suprastructures. Our study suggests an HS-dependent basic mechanism behind the altered wound repair phenotype of beta4GalT-7-deficient EDS patients.


Asunto(s)
Movimiento Celular , Síndrome de Ehlers-Danlos/fisiopatología , Galactosiltransferasas/metabolismo , Heparitina Sulfato/metabolismo , Cicatrización de Heridas , Actinas/metabolismo , Animales , Adhesión Celular , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/genética , Femenino , Fibrina/fisiología , Fibroblastos/citología , Fibronectinas/fisiología , Galactosiltransferasas/genética , Perfilación de la Expresión Génica , Glicosaminoglicanos/biosíntesis , Glicosaminoglicanos/genética , Heparitina Sulfato/química , Humanos , Lactante , Masculino , Ratones , Seudópodos/fisiología , ARN Interferente Pequeño , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Fibras de Estrés/metabolismo , Sindecano-4/genética , Sindecano-4/metabolismo
18.
J Biol Chem ; 282(9): 6588-96, 2007 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-17197443

RESUMEN

We have generated mice with targeted inactivation of the Plod1 gene for lysyl hydroxylase 1 (LH1). Its human mutations cause Ehlers-Danlos syndrome VIA (EDS VIA) characterized by muscular hypotonia, joint laxity, and kyphoscoliosis. The Plod1(-/-) mice are flaccid and have gait abnormalities. About 15% of them died because of aortic rupture and smooth muscle cells in non-ruptured Plod1(-/-) aortas showed degenerative changes. Collagen fibrils in the Plod1(-/-) aorta and skin had an abnormal morphology. The LH activity level in the Plod1(-/-) skin and aorta samples was 35-45% of that in the wild type. The hydroxylysine content was decreased in all the Plod1(-/-) tissues, ranging from 22% of that in the wild type in the skin to 75 and 86% in the femur and lung. The hydroxylysylpyridinoline crosslinks likewise showed decreases in all the Plod1(-/-) tissues, ranging from 28 and 33% of that in the wild type in the aorta and cornea to 47 and 59% in femur and tendon, while lysylpyridinolines were increased. The hydroxylysines found in the Plod1(-/-) collagens and their cross-links were evidently synthesized by the other two LH isoenzymes. Few data are available on abnormalities in EDS VIA tissues other than the skin. Plod1(-/-) mice offer an in vivo model for systematic analysis of the tissue-specific consequences of the lack of LH1 activity and may also provide a tool for analyzing the roles of connective tissue in muscle function and the complex interactions occurring in the proper assembly of the extracellular matrix.


Asunto(s)
Colágeno/química , Hidroxilisina/deficiencia , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/genética , Animales , Modelos Animales de Enfermedad , Síndrome de Ehlers-Danlos/enzimología , Síndrome de Ehlers-Danlos/patología , Síndrome de Ehlers-Danlos/fisiopatología , Marcha , Ratones , Ratones Endogámicos , Ratones Noqueados , Hipotonía Muscular/etiología , Fenotipo , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/deficiencia , Enfermedades de la Piel/etiología , Distribución Tisular
19.
Radiats Biol Radioecol ; 46(4): 424-8, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-17020091

RESUMEN

A complex investigation of different cell defence systems, such as: DNA repair, antioxidant system (SOD), xenobiotic detoxification system (glutathione-S-transferases M1 and T1), radioadaptive response (RAR) in lymphocytes of patients with hereditary disease of connective tissue (Elers-Danlose syndrome) was carried out. The frequency of genotype GSTM1 (0/0) in children with Elers-Danlose syndrome (23%) is lower as compared to the control group (44%). The lymphocytes of children with Elers-Danlose syndrome were characterized by reduced ability to repair gamma-induced damage of DNA. At given size of the samples of examined children no correlative relationships between GST-status of organism and the condition of other cell defence systems were revealed. The data obtained demonstrate the individual peculiarities of the defence systems in repair-deficient cells of the examined children.


Asunto(s)
Reparación del ADN/genética , Síndrome de Ehlers-Danlos/genética , Glutatión Transferasa/genética , Niño , ADN/análisis , Síndrome de Ehlers-Danlos/enzimología , Femenino , Humanos , Linfocitos/enzimología , Masculino , Polimorfismo Genético
20.
Development ; 133(8): 1587-96, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16556917

RESUMEN

Mutations in ADAMTS2, a procollagen amino-propeptidase, cause severe skin fragility, designated as dermatosparaxis in animals, and a subtype of the Ehlers-Danlos syndrome (dermatosparactic type or VIIC) in humans. Not all collagen-rich tissues are affected to the same degree, which suggests compensation by the ADAMTS2 homologs ADAMTS3 and ADAMTS14. In situ hybridization of Adamts2, Adamts3 and Adamts14, and of the genes encoding the major fibrillar collagens, Col1a1, Col2a1 and Col3a1, during mouse embryogenesis, demonstrated distinct tissue-specific, overlapping expression patterns of the protease and substrate genes. Adamts3, but not Adamts2 or Adamts14, was co-expressed with Col2a1 in cartilage throughout development, and with Col1a1 in bone and musculotendinous tissues. ADAMTS3 induced procollagen I processing in dermatosparactic fibroblasts, suggesting a role in procollagen I processing during musculoskeletal development. Adamts2, but not Adamts3 or Adamts14, was co-expressed with Col3a1 in many tissues including the lungs and aorta, and Adamts2(-/-) mice showed widespread defects in procollagen III processing. Adamts2(-/-) mice had abnormal lungs, characterized by a decreased parenchymal density. However, the aorta and collagen fibrils in the aortic wall appeared normal. Although Adamts14 lacked developmental tissue-specific expression, it was co-expressed with Adamts2 in mature dermis, which possibly explains the presence of some processed skin procollagen in dermatosparaxis. The data show how evolutionarily related proteases with similar substrate preferences may have distinct biological roles owing to tissue-specific gene expression, and provide insights into collagen biosynthesis and the pathobiology of dermatosparaxis.


Asunto(s)
Proteínas ADAM/metabolismo , Colágeno/biosíntesis , Síndrome de Ehlers-Danlos/enzimología , Procolágeno N-Endopeptidasa/metabolismo , Procolágeno/metabolismo , Procesamiento Proteico-Postraduccional/fisiología , Homología de Secuencia de Aminoácido , Proteínas ADAM/genética , Proteínas ADAMTS , Proteína ADAMTS4 , Animales , Huesos/embriología , Línea Celular , Colágeno Tipo II/biosíntesis , Colágeno Tipo II/genética , Dermis/enzimología , Síndrome de Ehlers-Danlos/genética , Fibroblastos/enzimología , Humanos , Ratones , Ratones Noqueados , Procolágeno N-Endopeptidasa/genética , Diente/embriología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA